Literature DB >> 21366647

Factors associated with compliance to thiazide diuretics among 8551 Chinese patients.

M C S Wong1, J Y Jiang, S M Griffiths.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Good compliance to anti-hypertensive medications has been recognized as a crucial factor to achieve optimal blood pressure control, but there were few studies addressing this issue among ethnic Chinese patients. This study aims to evaluate the factors associated with compliance to thiazide diuretics in a Chinese hypertensive population.
METHODS: From a clinical database, all adult Chinese patients aged ≥ 18 years who were prescribed a thiazide diuretic from the public health care sector in one large Territory of Hong Kong during January 2004 to June 2007 and attended at least twice for anti-hypertensive drug refill were included. Medication Possession Ratios were used to measure drug compliance for each patient, with a level ≥ 80% defined as compliant. We used binary logistic regression analysis to evaluate the factors associated with good compliance. RESULTS AND DISCUSSION: From 8551 eligible patients, 84·5% were compliant (defined as MPR ≥ 80%). Fee payers (adjusted odds ratio [aOR] 1·28; 95% CI 1·12-1·46, P < 0·001) and follow-up visitors (aOR 2·47, 95% CI 2·13-2·87, P < 0·001) were significantly associated with better anti-hypertensive compliance. Patients who were newly prescribed thiazide diuretics and those with poorer socioeconomic status were more likely to be non-compliant to anti-hypertensive therapies. Patients' age, gender and number of co-morbidities were not significant associated factors. WHAT IS NEW AND
CONCLUSION: Among Chinese patients, those who were newly prescribed thiazide diuretics and those with poorer socioeconomic status were more likely to be non-compliant to anti-hypertensive therapies. Closer monitoring and more intensive compliance-enhancing strategies had to be targeted towards these patients to enhance clinical outcomes.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366647     DOI: 10.1111/j.1365-2710.2010.01174.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  6 in total

Review 1.  Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.

Authors:  Tracey-Lea Laba; Beverley Essue; Merel Kimman; Stephen Jan
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community.

Authors:  Thi-Phuong-Lan Nguyen; Catharina C M Schuiling-Veninga; Thi Bach Yen Nguyen; Thu-Hang Vu; E Pamela Wright; Maarten J Postma
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

3.  Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale.

Authors:  Gabrielle K Y Lee; Harry H X Wang; Kirin Q L Liu; Yu Cheung; Donald E Morisky; Martin C S Wong
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

4.  Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study.

Authors:  Martin C S Wong; Wilson W S Tam; Clement S K Cheung; Harry H X Wang; Ellen L H Tong; Antonio C H Sek; Bryan P Y Yan; N T Cheung; Stephen Leeder; C M Yu; Sian Griffiths
Journal:  Int J Cardiol       Date:  2012-11-20       Impact factor: 4.164

5.  Medication adherence to first-line antihypertensive drug class in a large Chinese population.

Authors:  Martin C S Wong; Wilson W S Tam; Clement S K Cheung; Ellen L H Tong; Antonio C H Sek; N T Cheung; Stephen Leeder; Sian Griffiths
Journal:  Int J Cardiol       Date:  2012-05-03       Impact factor: 4.164

6.  Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study.

Authors:  Martin C S Wong; Wilson W S Tam; Harry H X Wang; Clement S K Cheung; Ellen L H Tong; Antonio C H Sek; N T Cheung; Bryan P Y Yan; C M Yu; Stephen R Leeder; Sian M Griffiths
Journal:  Int J Cardiol       Date:  2013-07-26       Impact factor: 4.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.